The purpose of this study is to assess conclusive efficacy of stem cells for the treatment of cerebral palsy in 45 subjects over 11 months.
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/RNL-BIO-filed-Phase-IIIII-Clinical-Trial-with-KFDA/ArticleNewsFeed/Article/detail/805050?ref=25
http://www.appliedclinicaltrialsonline.com/appliedclinicaltrials/Phase+News/RNL-BIO-filed-Phase-IIIII-Clinical-Trial-with-KFDA/ArticleNewsFeed/Article/detail/805050?ref=25
No comments:
Post a Comment